- Home
- KTTA vs GIGM Comparison
KTTA vs GIGM Comparison
Compare KTTA & GIGM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KTTA | GIGM |
|---|---|---|
| Founded | 2020 | 1998 |
| Country | United States | Taiwan |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.1M | 15.8M |
| IPO Year | 2021 | 2002 |
Fundamental Metrics
Financial Performance| Metric | KTTA | GIGM |
|---|---|---|
| Price | $0.52 | $1.38 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $3.00 | N/A |
| AVG Volume (30 Days) | ★ 214.9K | 4.0K |
| Earning Date | 05-14-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 77.07 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $486,559.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 3130.37 | N/A |
| 52 Week Low | $0.28 | $1.11 |
| 52 Week High | $2.06 | $1.84 |
Technical Indicators
Market Signals| Indicator | KTTA | GIGM |
|---|---|---|
| Relative Strength Index (RSI) | 47.80 | 48.61 |
| Support Level | $0.48 | $1.37 |
| Resistance Level | $0.52 | $1.54 |
| Average True Range (ATR) | 0.04 | 0.09 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 34.21 | 75.68 |
Price Performance
Historical ComparisonAbout KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. The disorders covered includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module). The Company has reportable segment, which is the business of research and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers.
About GIGM GigaMedia Limited
GigaMedia Ltd is a diversified provider of digital entertainment services. The only segment and principal business of the company is digital entertainment service business, that operates a portfolio of digital entertainment products, targeting digital entertainment service users across Asia. The company operates digital entertainment business in Taiwan, Hong Kong and Macau through FunTown. The company generates majority revenue from Taiwan.